patient selection for aflibercept in advanced crc
Published 8 years ago • 98 plays • Length 4:08Download video MP4
Download video MP3
Similar videos
-
6:33
patient selection for regorafenib in crc
-
6:26
role of the vegf inhibitor aflibercept in metastatic colorectal cancer
-
1:05
dr. peeters on the utility of aflibercept in advanced colorectal cancer
-
11:36
panitumumab, regorafenib, and ziv-aflibercept in metastatic colorectal cancer
-
5:30
treatment options for advanced colorectal cancer
-
1:18
dr. richard kim on administering aflibercept in colorectal cancer
-
13:11
treatment sequencing in metastatic colorectal cancer
-
1:08
dr. holcombe discusses aflibercept for mcrc
-
5:57
case studies in advanced colorectal cancer
-
3:26
maintenance and second-line decisions in crc
-
12:16
selecting the optimal first-line treatment in advanced colorectal cancer
-
5:32
frontline antibody selection in metastatic crc
-
15:00
controversy debate 4: treatment algorithms in metastatic crc - nccn guidelines
-
6:11
immunotherapy in crc
-
6:24
immunotherapy options in refractory crc
-
1:07
dr. ruff on aflibercept in elderly patients with colorectal cancer
-
11:15
debate: borderline resectable liver metastasis in ras wt crc? - folfox (or folfoxiri)/bev
-
8:46
antibody selection and right- versus left-sided colorectal cancer
-
4:41
molecular testing for metastatic crc in 2020